Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. Silagy AW, Woon DTS, Kostos L, Bernardino R, et al. BJU Int 2025 Apr 25. doi: 10.1111/bju.16751.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silagy AW, Woon DTS, Kostos L, Bernardino R, et al. Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. BJU Int 2025 Apr 25. doi: 10.1111/bju.16751.
PMID: 40275794